Normal cells

Ras

l Aciivaied

MAPK Ras mulalion

ELK1

MED23 aner selection
l .

Parallel

Normal Growth

Pathways

 

Cancer cells

Ras
l
MAPK
l
ELK1
l
MED23

l

Oncogenic
Addiction

Cancer cells
I Targeting MED23, ELK1, gr:
1 meirinieiaciion interface j
3 inhibitors

  

Reduced Prolileration

